followed by maintenance doses of 1 mg every 2-3 months) Importantly, if neurological symptoms are present, treatment should be started urgently and not delayed for test results
Wegovy contains the same active ingredient as Ozempic (semaglutide) but is FDA-approved for chronic weight management and cardiovascular risk reduction
People who experience acid reflux with GLP-1 agents may find that the nausea from Pendulum triggers similar symptoms
85 Dulaglutide 1.5 mg has demonstrated non-inferiority in diabetes control compared to liraglutide 1.8 mg, and comparable weight reduction efficacy to oral SEMA (Orforglipron) 3 mg
The Medicines and Healthcare products Regulatory Agency (MHRA) has approved these medications for specific uses, primarily type 2 diabetes management and, in some cases, weight management
The findings have raised questions, especially as the number of people using semaglutide medications continues to climb